Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $1.09 Million |
|---|---|
| Enterprise Value | $1.96 Million |
| Earnings per Share | $0 |
| Beta | 7.92 |
| Outstanding Shares | 10,919,428,835 |
| P/E Ratio | -4.55 |
|---|---|
| PEG | -4.45 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 2.41 |
| Enterprise Value to EBIT | -6.53 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.44 |
| Debt to Equity | -0.2 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Herborium Group, Inc. operates as a specialized firm in botanical therapeutics, focusing on the creation, licensing, and commercialization of its unique, plant-based medicinal goods for both general consumers and healthcare professionals...